| scholarly article | Q13442814 |
| P2093 | author name string | J Vassallo | |
| R Formosa | |||
| J Borg | |||
| P2860 | cites work | Cloning of the Ah-receptor cDNA reveals a distinctive ligand-activated transcription factor | Q24564124 |
| An endogenous tumour-promoting ligand of the human aryl hydrocarbon receptor | Q28249782 | ||
| The regulation of E2F by pRB-family proteins | Q28278789 | ||
| A direct interaction between the aryl hydrocarbon receptor and retinoblastoma protein. Linking dioxin signaling to the cell cycle | Q28280266 | ||
| p27(Kip1) induction and inhibition of proliferation by the intracellular Ah receptor in developing thymus and hepatoma cells | Q28343428 | ||
| Aryl hydrocarbon receptor imported into the nucleus following ligand binding is rapidly degraded via the cytosplasmic proteasome following nuclear export | Q28373219 | ||
| Characterization of a murine Ahr null allele: involvement of the Ah receptor in hepatic growth and development | Q28507862 | ||
| Cytochrome P4501A1 promotes G1 phase cell cycle progression by controlling aryl hydrocarbon receptor activity | Q28573600 | ||
| Influence of TCDD and natural Ah receptor agonists on benzo[a]pyrene-DNA adduct formation in the Caco-2 human colon cell line. | Q33309150 | ||
| Signaling pathway networks mined from human pituitary adenoma proteomics data | Q33567346 | ||
| Induction of cytochrome P4501A1. | Q33636653 | ||
| Persistent binding of ligands to the aryl hydrocarbon receptor | Q33803848 | ||
| Reduced expression levels of the cell-cycle inhibitor p27Kip1 in human pituitary adenomas | Q48227723 | ||
| Pituitary adenoma predisposition caused by germline mutations in the AIP gene. | Q51585727 | ||
| The aryl hydrocarbon receptor: studies using the AHR-null mice. | Q52181333 | ||
| AIP mutations impair AhR signaling in pituitary adenoma patients fibroblasts and in GH3 cells. | Q53203358 | ||
| Analysis of differential gene expression by fiber-optic BeadArray and pathway in prolactinomas. | Q54405168 | ||
| Expression and Clinical Significance of Wnt Players and Survivin in Pituitary Tumours | Q57584839 | ||
| Molecular pathogenesis of human prolactinomas identified by gene expression profiling, RT-qPCR, and proteomic analyses | Q58471874 | ||
| Novel Molecular Signaling and Classification of Human Clinically Nonfunctional Pituitary Adenomas Identified by Gene Expression Profiling and Proteomic Analyses | Q58471883 | ||
| Expression analysis of cyclins in pituitary adenomas and the normal pituitary gland | Q60586400 | ||
| Characterization of the activated form of the aryl hydrocarbon receptor in the nucleus of HeLa cells in the absence of exogenous ligand | Q71053853 | ||
| Inhibitory effects of 2,3,7,8-tetrachlorodibenzo-p-dioxin on rat hepatocyte proliferation induced by 2/3 partial hepatectomy | Q71716442 | ||
| Cyclin D and cyclin E expression in normal and adenomatous pituitary | Q73931402 | ||
| Cyclins D1 and D3 and topoisomerase II alpha in inactive pituitary adenomas | Q74290119 | ||
| Prevalence and incidence of pituitary adenomas: a population based study in Malta | Q85651502 | ||
| A constitutively active dioxin/aryl hydrocarbon receptor induces stomach tumors | Q34098524 | ||
| The aryl hydrocarbon receptor functions as a tumor suppressor of liver carcinogenesis | Q34128053 | ||
| Cancer Immunotherapy by Targeting IDO1/TDO and Their Downstream Effectors | Q34913785 | ||
| Whole-exome sequencing studies of nonfunctioning pituitary adenomas | Q35661976 | ||
| p21, an important mediator of quiescence during pituitary tumor formation, is dispensable for normal pituitary development during embryogenesis | Q35809432 | ||
| Expression of the aryl hydrocarbon receptor is not required for the proliferation, migration, invasion, or estrogen-dependent tumorigenesis of MCF-7 breast cancer cells | Q36208050 | ||
| Aryl hydrocarbon receptor, cell cycle regulation, toxicity, and tumorigenesis | Q36279973 | ||
| Aryl-hydrocarbon receptor activity modulates prolactin expression in the pituitary | Q36374112 | ||
| The aromatic hydrocarbon receptor modulates the Hepa 1c1c7 cell cycle and differentiated state independently of dioxin | Q36559117 | ||
| Identification of stanniocalcin 2 as a novel aryl hydrocarbon receptor target gene | Q36642405 | ||
| p21(Cip1) restrains pituitary tumor growth | Q36960715 | ||
| The selective aryl hydrocarbon receptor modulator 6-methyl-1,3,8-trichlorodibenzofuran inhibits prostate tumor metastasis in TRAMP mice. | Q37137946 | ||
| The aryl hydrocarbon receptor has a normal function in the regulation of hematopoietic and other stem/progenitor cell populations. | Q37150677 | ||
| A new cross-talk between the aryl hydrocarbon receptor and RelB, a member of the NF-kappaB family | Q37207403 | ||
| Identification of cinnabarinic acid as a novel endogenous aryl hydrocarbon receptor ligand that drives IL-22 production. | Q37549093 | ||
| Insulin like growth factor 2 regulation of aryl hydrocarbon receptor in MCF-7 breast cancer cells | Q37599287 | ||
| Ah receptor-mediated suppression of liver regeneration through NC-XRE-driven p21Cip1 expression | Q37663370 | ||
| Wnt signalling in pituitary development and tumorigenesis | Q38108137 | ||
| Role of aryl hydrocarbon receptor in cancer. | Q38109748 | ||
| cAMP in the pituitary: an old messenger for multiple signals. | Q38139345 | ||
| cAMP signalling in the normal and tumorigenic pituitary gland | Q38213197 | ||
| The PI3K/AKT/mTOR pathway in the pathophysiology and treatment of pituitary adenomas | Q38232872 | ||
| AHR- and DNA-damage-mediated gene expression responses induced by benzo(a)pyrene in human cell lines. | Q38297264 | ||
| Differential gene expression in pituitary adenomas by oligonucleotide array analysis | Q38324132 | ||
| Constitutive activation of the aromatic hydrocarbon receptor | Q39631404 | ||
| The aryl hydrocarbon receptor activator benzo[a]pyrene enhances vitamin D3 catabolism in macrophages | Q39879598 | ||
| The dioxin receptor is silenced by promoter hypermethylation in human acute lymphoblastic leukemia through inhibition of Sp1 binding. | Q40330519 | ||
| The aryl hydrocarbon receptor displaces p300 from E2F-dependent promoters and represses S phase-specific gene expression | Q40559925 | ||
| Whole-Genome Sequencing of Growth Hormone (GH)-Secreting Pituitary Adenomas. | Q40635984 | ||
| Constitutive and TCDD-induced expression of Ah receptor-responsive genes in the pituitary. | Q40678544 | ||
| Aromatic hydrocarbon receptor interaction with the retinoblastoma protein potentiates repression of E2F-dependent transcription and cell cycle arrest | Q41715731 | ||
| Leukocyte activation induces aryl hydrocarbon receptor up-regulation, DNA binding, and increased Cyp1a1 expression in the absence of exogenous ligand | Q42545838 | ||
| Expression of aryl hydrocarbon receptor (AHR) and AHR-interacting protein in pituitary adenomas: pathological and clinical implications. | Q43857299 | ||
| A constitutively active arylhydrocarbon receptor induces growth inhibition of jurkat T cells through changes in the expression of genes related to apoptosis and cell cycle arrest | Q44833733 | ||
| A constitutively active dioxin/aryl hydrocarbon receptor promotes hepatocarcinogenesis in mice | Q44980767 | ||
| From pituitary adenoma to pituitary neuroendocrine tumor (PitNET): an International Pituitary Pathology Club proposal | Q45054086 | ||
| Activation of RAF/MEK/ERK and PI3K/AKT/mTOR pathways in pituitary adenomas and their effects on downstream effectors. | Q45924639 | ||
| Effects of perfluoroalkyl acids on the function of the thyroid hormone and the aryl hydrocarbon receptor | Q46316312 | ||
| Somatostatin analogues increase AIP expression in somatotropinomas, irrespective of Gsp mutations. | Q46649628 | ||
| Evidence that ligand binding is a key determinant of Ah receptor-mediated transcriptional activity. | Q46682699 | ||
| Molecular mechanisms of p21 and p27 induction by 3-methylcholanthrene, an aryl-hydrocarbon receptor agonist, involved in antiproliferation of human umbilical vascular endothelial cells | Q46893655 | ||
| P275 | copyright license | Creative Commons Attribution 4.0 International | Q20007257 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P433 | issue | 8 | |
| P304 | page(s) | 445-457 | |
| P577 | publication date | 2017-06-25 | |
| P1433 | published in | Endocrine-Related Cancer | Q3054004 |
| P1476 | title | Aryl hydrocarbon receptor (AHR) is a potential tumour suppressor in pituitary adenomas | |
| P478 | volume | 24 |
Search more.